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Global Regulator of Virulence A (GrvA) Coordinates Expression of
Discrete Pathogenic Mechanisms in Enterohemorrhagic Escherichia
coli through Interactions with GadW-GadE
Jason K. Morgan,

Ronan K. Carroll, Carly M. Harro, Khoury W. Vendura, Lindsey N. Shaw, James T. Riordan

University of South Florida, Department of Cell Biology, Microbiology and Molecular Biology, Tampa, Florida, USA

ABSTRACT

IMPORTANCE

Enterohemorrhagic Escherichia coli (EHEC) is an intestinal human pathogen causing acute hemorrhagic colitis and life-threatening hemolytic-uremic syndrome. For successful transmission and gut colonization, EHEC relies on the glutamate-dependent
acid resistance (GDAR) system and a type III secretion apparatus, encoded on the LEE pathogenicity island. This study investigates the mechanism whereby the DNA-binding regulator GrvA coordinates activation of the LEE with repression of GDAR. Investigating how these systems are regulated leads to an understanding of pathogenic behavior and novel strategies aimed at disease prevention and control.

E

nterohemorrhagic Escherichia coli (EHEC) O157:H7 is a virulent intestinal pathogen causing foodborne outbreaks of
bloody diarrhea (hemorrhagic colitis) and the life-threatening
kidney disease hemolytic-uremic syndrome (1–3). Competitive
colonization of the intestine by EHEC requires a type III secretion
(T3S) mechanism and is characterized by the formation of attaching-and-effacing (A/E) lesions (1, 2). The T3S apparatus is encoded on a pathogenicity island, referred to as the locus of enterocyte effacement (LEE), containing 41 genes organized into five
operons (LEE1 to LEE5) (4). The master LEE regulator, Ler, encoded as the first gene of LEE1, positively stimulates LEE transcription by relieving H-NS-mediated repression. Ler further activates the LEE-encoded regulators GrlA and GrlR, which in turn
activate and repress ler transcription, respectively (5–10). Numerous non-LEE-encoded regulators also converge on ler and grlA
promoters to coordinate LEE-dependent colonization with environmental/physiological cues (11–19).
One such regulator, RcsB, has been shown to both activate and
repress LEE transcription and more recently has been shown to be
required for induction of the LEE in response to the bicarbonate
ion (20, 21). RcsB is the response regulator of the Rcs phosphorelay system, a multicomponent signaling pathway including RcsC
(sensor kinase), RcsD (histidine phosphotransferase), and RcsF
(outer membrane lipoprotein) (22–26). Upon phosphorylation,
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RcsB can bind to target promoters as a homodimer and as a heterodimer in conjunction with other regulatory auxiliary proteins,
such as RcsA, BglJ, and GadE (27–29). Binding occurs at specific
RcsB consensus sites (30, 31), and the location of binding relative
to the ⫺35 consensus sequence can dictate whether RcsB positively or negatively affects transcription (32). Tobe et al. (21) demonstrated that upregulation of the LEE effector EspB in response
to rcsB overexpression also required the transcriptional regulator
GrvA (for global regulator of virulence A). Furthermore, the overexpression of grvA was shown to activate transcription from the ler
promoter (LEE1 operon) and to increase adherence to Caco-2
cells in vitro. In a subsequent study by Morgan et al. (20), both rcsB
and grvA were shown to be required for bicarbonate induction of
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Global regulator of virulence A (GrvA) is a ToxR-family transcriptional regulator that activates locus of enterocyte effacement
(LEE)-dependent adherence in enterohemorrhagic Escherichia coli (EHEC). LEE activation by GrvA requires the Rcs phosphorelay response regulator RcsB and is sensitive to physiologically relevant concentrations of bicarbonate, a known stimulant of virulence systems in intestinal pathogens. This study determines the genomic scale of GrvA-dependent regulation and uncovers
details of the molecular mechanism underlying GrvA-dependent regulation of pathogenic mechanisms in EHEC. In a grvA-null
background of EHEC strain TW14359, RNA sequencing analysis revealed the altered expression of over 700 genes, including the
downregulation of LEE- and non-LEE-encoded effectors and the upregulation of genes for glutamate-dependent acid resistance
(GDAR). Upregulation of GDAR genes corresponded with a marked increase in acid resistance. GrvA-dependent regulation of
GDAR and the LEE required gadE, the central activator of GDAR genes and a direct repressor of the LEE. Control of gadE by
GrvA was further determined to occur through downregulation of the gadE activator GadW. This interaction of GrvA with
GadW-GadE represses the acid resistance phenotype, while it concomitantly activates the LEE-dependent adherence and secretion of immune subversion effectors. The results of this study significantly broaden the scope of GrvA-dependent regulation and
its role in EHEC pathogenesis.

GrvA-Dependent Regulation of EHEC Pathogenesis

MATERIALS AND METHODS
Bacterial strains and growth conditions. The strains and plasmids used
in this study are listed in Table 1. Strains were stocked at ⫺80°C in glycerol
diluted (final concentration, 15%, vol/vol) in Luria broth (LB) and were
maintained in LB or on LB with 1.5% agar (LBA). Unless otherwise noted,
overnight (18- to 20-h) cultures grown in LB were used to inoculate fresh
LB or LB buffered with sodium bicarbonate (44 mM NaHCO3) or fresh
Dulbecco’s modified Eagle’s medium (DMEM; 4 g/liter glucose, 4 mM
glutamine, 44 mM NaHCO3, pH 7.4) to a final optical density at 600 nm
(OD600) of 0.05. Cultures were grown at 37°C in a rotary shaker (200 rpm)
using a 1:10 medium-to-flask volume. Antibiotics (Sigma-Aldrich) were
added to the cultures when required.
Genetic manipulations and complementation. Primers used for genetic manipulation and complementation are available upon request. For
construction of deletion mutants, the bacteriophage  Red-assisted onestep deletion method adapted for EHEC was used as described previously
(20, 34, 35). Complementation of rcsB was performed using vector pRJM20, as previously described (20). Additionally, a fragment containing the
entire rcsDB operon, including the rcsD promoter region (nucleotide positions 3041665 to 3046191; GenBank accession number NC_013008.1),
was cloned into BamHI/XbaI-digested low-copy-number expression vector pMPM-K3 (Kanr) (36) using primers RcsB⫺3732/BamHI and
RcsB⫹794/XbaI to produce pRJM-21. To complement grvA, a PCR product corresponding to the grvA open reading frame (ORF) and including a
267-bp upstream region of grvA containing the predicted promoter (nucleotide positions 1281984 to 1283134; GenBank accession number
NC_013008.1) was produced using primers GrvA⫺268/XhoI and
GrvA⫹884/BamHI and cloned into XhoI/BamHI-digested low-copynumber expression vector pMPM-A2 (Ampr), creating pRJM-22. To
complement gadE, a PCR product corresponding to the gadE ORF and
762 bp of the sequence upstream of gadE (containing the native promoters, nucleotide positions 4458857 to 4460195) was produced using primers GadE⫺763/XbaI and GadE⫹577/BamHI and cloned into the XbaI/
BamHI-digested vector pMPM-A2 to create pRJM-30. Confirmation of
genetic constructs was done using a combination of restriction mapping
and DNA sequencing (MWG Operon).
RNA purification and qRT-PCR. The primers used for quantitative
real-time PCR (qRT-PCR) are available upon request. RNA purification,
cDNA synthesis, qRT-PCR cycling conditions, and data analysis followed
previously described protocols (37) using a Realplex2 Mastercycler instrument (Eppendorf). Cycle threshold (CT) data were normalized to the
level of rrsH (16S rRNA gene) expression, and normalized cycle threshold
(⌬CT) values were transformed to arbitrary transcript expression levels
using 2⫺⌬CT/10⫺6, as described previously (38, 39). Expression levels were
compared statistically by the appropriate t test or by Tukey’s honestly
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significant difference (HSD) test following a significant F test (n ⱖ 3, ␣ ⫽
0.05; R software, version 3.1.0).
Construction of a single-copy grvAB-luxE operon fusion. A strain
containing a single-copy chromosome-plasmid luxE reporter fusion was
constructed using a protocol adapted from that of Shimizu et al. (40). To
make a grvAB-luxE fusion, the kan cassette and flanking FLP recombination target sites were amplified from pKD4 (34) using primers
pKD4forward/SacI and pKD4reverse/BamHI. This product was SacI/
BamHI digested and cloned into the BamHI/SacI site of pMPM-T3 to
produce pMPM-T3-kan. A XhoI/BamHI-digested PCR product containing the luxE gene and native ribosome binding site was amplified from
placlux8 (40) using primers LuxE-18/XhoI and LuxE⫹1,450/BamHI
and cloned into the XhoI/BamHI site of similarly digested pMPM-T3kan to create pMPM-T3-luxE-kan. The luxE-kan PCR product amplified from pMPM-T3-luxE-kan using primers GrvA⫹1,283/LuxE and
GrvA⫹1,431/P2 and Phusion high-fidelity DNA polymerase (NEB)
was fused to a region 13 bp downstream of the grvAB operon using
bacteriophage  Red recombination (34). Kanamycin resistance cassettes were removed using FLP recombinase as described previously
(34), and the grvAB-luxE construct was validated using a combination
of restriction mapping and DNA sequencing (MWG Operon). The lux
operon genes luxCDAB were constitutively expressed in trans in
TW14359 grvAB-luxE from pluxCDAB3 (40, 41).
Luciferase activity. Overnight cultures grown in LB and DMEM were
used to inoculate fresh LB or DMEM, respectively, to an initial OD600 of
0.05. To measure the effect of sodium bicarbonate (NaHCO3) on grvA
expression, LB test cultures were grown with and without addition of 44
mM NaHCO3 (all DMEM cultures contained 44 mM NaHCO3). Cultures
(0.2 ml) were inoculated into 96-well, clear-bottom white-walled plates
(catalog number 655098; Greiner Bio-One) and incubated at 37°C in a
rotary shaker (200 rpm). Luciferase and OD600 measurements were taken
every hour for 10 h using a BioTek Synergy 2 plate reader (1 s integration)
prewarmed to 37°C. Mean luciferase activity was compared between treatments (medium and NaHCO3 effects) using the appropriate t test (n ⫽ 4,
␣ ⫽ 0.05; R software, version 3.1.0).
EMSAs. Electrophoretic mobility shift assays (EMSAs) were performed as previously described (42). Briefly, the forward primers
RcsB⫹4/NcoI and RcsB⫹682/XhoI, used to PCR amplify rcsB from
TW14359 DNA, contained a new start codon and an N-terminal 6⫻His
epitope tag, and the PCR product was cloned into the NcoI/XhoI sites of
similarly digested vector pET-24d to create pRJM-27. N-terminal 6⫻HisRcsB fusion proteins have wild-type RcsB activity (43). 6⫻His-RcsB was
purified from strain BL21(DE3)pLysS using Ni-nitrilotriacetic acid spin
columns (Qiagen) according to the manufacturer’s protocol. Briefly,
overnight LB cultures containing 1 mM IPTG (isopropyl-␤-D-thiogalactopyranoside) and kanamycin (50 g/ml) grown at 18°C (200 rpm) were
pelleted and resuspended in 1.5 ml of lysis buffer (10 mM imidazole, 300
mM NaCl, 50 mM NaH2PO4, pH 8.0) and lysed by sonication for 3 min
(50% amplitude, 10-s intervals, 30-s pause) while they were chilled on ice.
The lysate was centrifuged at 21,000 ⫻ g to remove insoluble cellular
debris, and the supernatant was used for column purification and subsequently eluted with elution buffer (500 mM imidazole, 300 mM NaCl, 50
mM NaH2PO4, pH 8.0). Purified 6⫻His-RcsB protein was quantified
using a Bradford protein assay. Five prime biotin-labeled primers (Integrated DNA Technologies oligonucleotides) were used to generate a
probe containing the grvA promoter (grvAP) region, including putative
RcsB consensus binding sites (Frag-2F and Frag-2R) (Fig. 1B). An additional upstream grvA promoter probe with no predicted RcsB consensus
sequence was amplified for use as a negative control (Frag-1F and Frag1R) (Fig. 1B). Biotin-labeled probes were gel purified using QIAquick gel
extraction kits (Qiagen) and diluted to a concentration of 0.5 ng/l. All
EMSAs were performed using a LightShift chemiluminescent EMSA kit
(Thermo Pierce) according to the manufacturer’s specifications. Prior to
electrophoresis, purified 6⫻His-RcsB and biotin-labeled fragments were
coincubated for 40 min in binding buffer (1⫻ binding buffer, 50 ng/l
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the LEE. Collectively, these two studies reveal GrvA to be an activator of Ler that can interact with RcsB to communicate the bicarbonate signal to the LEE colonizing mechanism.
How RcsB controls grvA and how GrvA, in turn, controls LEE
expression are not known. GrvA shares homology with ToxRfamily protein regulators, such as MarT in Salmonella enterica
(30% amino acid identity) and CadC in E. coli (13% amino acid
identity). Both MarT and CadC are transcriptional activators,
with the latter activating the cadBA operon by displacing H-NSmediated repression (33). The similarity of GrvA to MarT and
CadC largely resides in the N terminus, containing a conserved
DNA-binding helix-turn-helix domain (COG3710) and a CheYlike response regulator receiver domain (COG0745). In this study,
details of the molecular basis for grvA regulation and for GrvAdependent control of the LEE and LEE-dependent adherence are
determined. Furthermore, global RNA sequencing analysis significantly broadens our knowledge of the role for GrvA in regulation
to include genes central to acid resistance and metabolic fitness.

Morgan et al.

TABLE 1 Strains and plasmids used in this study
Relevant characteristics

Reference or source

Strains
DH5␣
BL21(DE3)pLysS
TW14359
EcRJM-1
EcRJM-6
EcRJM-10
EcRJM-11
EcRJM-12
EcRJM-13
EcRJM-35
EcRJM-72
EcRJM-73
EcRJM-74
EcRJM-75
EcRJM-76
EcRJM-77
EcRJM-78
EcRJM-79
EcRJM-80
EcRJM-81
EcRJM-82
EcRJM-110
EcRJM-83
EcRJM-84
EcRJM-85
EcRJM-86
EcRJM-87
EcRJM-88
EcRJM-89
EcRJM-90
EcRJM-91
EcRJM-92
EcRJM-93
EcRJM-94
EcRJM-95
EcRJM-96
EcRJM-97
EcRJM-98
EcRJM-99
EcRJM-100
EcRJM-101
EcRJM-102
EcRJM-103
EcRJM-104
EcRJM-105
EcRJM-106
EcRJM-107
EcRJM-108
EcRJM-109

Vector propagation, recA1 endA1
BL21 with IPTG-inducible T7 polymerase
Wild-type strain from the 2006 outbreak, western USA
TW14359 ⌬escN
TW14359 ⌬rcsB
TW14359 rcsB-FLAG
TW14359 ⌬grvA
TW14359 ⌬rcsB ⌬grvA
TW14359 tir-FLAG
TW14359 ⌬grlR::kan
TW14359 ⌬rcsB/pRJM-20
TW14359 ⌬lacZ
TW14359/pRJM-23
TW14359/pRJM-24
TW14359/pRJM-25
TW14359/pRJM-26
TW14359 ⌬grvA/pRJM-23
TW14359 ⌬grvA/pRJM-24
TW14359 ⌬grvA/pRJM-25
TW14359 ⌬grvA/pRJM-26
TW14359 ⌬grvA ⌬gadE::kan/pRJM-24
TW14359 ⌬grvA ⌬gadE::kan/pRJM-26
TW14359 ⌬grvA/pRJM-22
TW14359 ⌬rcsB ⌬grvA/pRJM-22
TW14359 ⌬rcsB ⌬grvA/pRJM-20
TW14359 rcsDB-luxE
TW14359 grvAB-luxE
TW14359 rcsDB-luxE/pluxCDAB3
TW14359 grvAB-luxE/pluxCDAB3
TW14359 ⌬gadE::kan
TW14359 ⌬grvA ⌬gadE::kan
TW14359 ⌬gadE::kan/pRJM-30
TW14359 ⌬grvA ⌬gadE::kan/pRJM-30
TW14359 zinT-FLAG::kan
TW14359 ⌬grvA zinT-FLAG::kan
TW14359/pRJM-31
EPECa E2348/69/pRJM-31
MG1655/pRJM-31
DH5␣/pRJM-31
TW14359/pRJM-32
EPEC E2348/69/pRJM-32
MG1655/pRJM-32
DH5␣/pRJM-32
TW14359 rcsDB-luxE/pluxCDAB3/pRJM-21
TW14359 grvAB-luxE/pluxCDAB3/pRJM-21
TW14359 ⌬grvA/pRJM-23
TW14359 ⌬grvA/pRJM-24
TW14359 ⌬grvA/pRJM-25
TW14359 ⌬grvA/pRJM-26

90
91
20
20
20
20
20
20
20
20
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

Plasmids
pACYC177
pBAD22
pMPM-A2
pMPM-K3
pMPM-T3
pUC19
pRS551
pCP20
pKD4
pKM208

Low-copy-no. cloning vector, Ampr Kanr P15A
Ara-inducible expression vector, Ampr M13
Low-copy-no. cloning vector, Ampr pMB1/f1
Low-copy-no. cloning vector, Kanr p15A/f1
Low-copy-no. cloning vector, Tetr p15A/f1
High-copy-no. cloning vector, Ampr pMB1
lac fusion vector, Ampr Kanr lacZ⫹ ColE1
FLP recombinase expression vector
Template plasmid for Kan cassette
Bacteriophage  Red recombinase expression vector

92
36
36
36
93
34
34
34
(Continued on following page)
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Strain or plasmid

GrvA-Dependent Regulation of EHEC Pathogenesis

TABLE 1 (Continued)
Strain or plasmid

a
b

Reference or source
r

T7 promoter, His tag vector, Kan f1, pBR322
FLAG epitope template, Ampr Kanr, R6K
pACYC177-rcsB
pACYC177-grvAB
pMPM-K3-rcsDB
pMPM-A2-grvA
pRS551-gadEP(⫺773, ⫺1)b
pRS551-gadEP(⫺320, ⫺1)
pRS551-gadEP(⫺516, ⫺276)
pRS551-gadEP(⫺773, ⫺497)
pET-24d-6⫻His-rcsB
pMPM-T3-kan
pMPM-T3-luxE-kan
pMPM-A2-gadE
pRS551-grvAP(⫺268, ⫹38)
pUC-grvA-6⫻His
placlux8
pLuxCDAB3

Novagen
94
20
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
40
40

EPEC, enteropathogenic E. coli.
The numbers indicate the positions in gadEP.

sheared salmon sperm DNA, 2.5% glycerol, 0.05% NP-40, 5 mM MgCl2,
50 mM KCl, 1 mM EDTA) at room temperature. Samples were loaded
into a prerun and cooled 8% native polyacrylamide gel and run at 20 V/cm
for 1 h. Following electrophoresis, biotin-labeled DNA was transferred
(25 V for 20 min) to a Biodyne B precut modified nylon membrane
(Thermo Pierce) and UV cross-linked for 60 s. Biotin-labeled DNA fragments were detected using streptavidin-horseradish peroxidase-conjugated antibodies (1:300) in blocking buffer, and the membranes were
washed, equilibrated, and subsequently detected using luminol/enhancer
solutions in a ChemiDoc XRS⫹ imaging system and Image Lab (version
3.0) software (Bio-Rad).
Construction of lacZ transcriptional fusions and ␤-galactosidase
assays. Construction of a grvAP-lacZ reporter transcriptional fusion followed a previously described protocol using pRS551 (Table 1) (20).
Briefly, a 306-bp PCR product containing the predicted grvA promoter
was amplified from TW14359 genomic DNA using primers GrvA⫺268/
EcoRI and GrvA⫹38/BamHI, BamHI/EcoRI digested, and then cloned
into similarly digested pRS551, resulting in pRJM-31. Four different
gadEP-lacZ promoter fusions were created by cloning BamHI/EcoRI-digested PCR products into similarly digested pRS551 using primers
GadE⫺320/EcoRI and GadE⫺1/BamHI, GadE⫺276/EcoRI and
GadE⫺516/BamHI, GadE⫺773/EcoRI and GadE⫺497/BamHI, and
GadE⫺773/EcoRI and GadE⫺1/BamHI. ␤-Galactosidase activity (Miller
units) was measured as previously described (38, 44), and the numbers of
Miller units were compared using the appropriate t test or by Tukey’s HSD
test following a significant F test (n ⱖ 3, ␣ ⫽ 0.05; R software, version
3.1.0).
RNA sequencing and data analysis. RNA extractions were performed
as described above for qRT-PCR, except that residual genomic DNA was
digested using Turbo DNase (catalog number AM2238; Ambion) following the manufacturer’s protocol. Three independent RNA samples for
each strain (TW14359 and TW14359 ⌬grvA) were pooled into a single
sample (n ⫽ 1) in a 1:1:1 ratio to account for intersample variability, and
rRNA was removed using a MICROBExpress bacterial mRNA enrichment kit (catalog number AM1905; Ambion) according to the manufacturer’s instructions. The integrity and concentration of purified and enriched mRNA were determined using an Agilent 2100 bioanalyzer
(Agilent Technologies). RNA sequencing (RNA-seq) was performed as
previously described (45). Briefly, mRNA was converted to strand-specific cDNA using an Ion Total RNA-Seq kit (version 2; catalog number
4475936; Ion Torrent), and samples were sequenced using an Ion Per-
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sonal Genome Machine (PGM) system (Ion Torrent). Sequence mapping
and data analysis were performed using CLC Genomics Workbench (version 6) software (CLC Bio). Subsequent reads per kilobase per million
mapped reads (RPKM) values were converted to the fold change for
TW14359 ⌬grvA relative to the value for wild-type strain TW14359. Circular plots were created using Circos (version 0.65) software (http://www
.circos.ca) (46).
Intestinal cell adherence assays. The maintenance and culture of
HT-29 colonic intestinal cells were performed as previously described
(20). Adherence competition indexes were determined using the method
of Gabbianelli et al. (47). Briefly, overnight DMEM cultures were used to
inoculate fresh DMEM to an OD600 of 0.05, and these were then incubated
for 3 h at 37°C with shaking (200 rpm). Cultures were then diluted to an
OD600 of 0.5 and mixed in a 1:1 ratio (test strain/control strain), and 0.2
ml of each was used to inoculate HT-29 cells in 6-well culture plates. A
control strain incapable of utilizing lactose (a Lac⫺ strain) was constructed by deleting the entire lacZ ORF in TW14359 (strain EcRJM-73)
using the bacteriophage  Red approach and deletion primers LacZ⫺1/P1
and LacZ⫹3115/P2 (primer sequences are available upon request). Each
plate was gently mixed before centrifugation at 500 ⫻ g for 5 min and then
incubated as described above. Following 3 h of incubation, each well was
washed four times using sterile phosphate-buffered saline (PBS) to remove nonadherent cells, and adherent cells were removed using 500 l of
0.1% Triton X-100. Cells were enumerated (number of CFU per milliliter) by serial dilution in PBS and plating onto MacConkey agar, which is
differential for lactose utilization. After overnight growth on MacConkey
agar, pink (Lac-positive [Lac⫹]) colonies were scored as the numbers of
CFU per milliliter for the test strain, whereas white (Lac-negative [Lac⫺])
colonies were scored as the numbers of CFU per milliliter for strain
TW14359 ⌬lacZ. The competitive index was derived by dividing the numbers of CFU per milliliter of the test strain by the numbers of CFU per
milliliter of TW14359 ⌬lacZ, and the indexes were compared statistically
using the appropriate t test (n ⱖ 3, ␣ ⫽ 0.05; R software, version 3.1.0).
Test for acid resistance. Acid resistance by the glutamate-dependent
system was measured as described previously (37) with slight adaptations.
Mid-exponential-phase (OD600 ⫽ 0.5) DMEM cultures were inoculated
to a 106-CFU/ml final cell density in E minimal glucose (EG) medium
with or without 5.7 mM L-glutamate at pH 7 (control) or acidified with
HCl (pH 2). For cell count (number of CFU per milliliter) and percent
survival determinations, samples were serially diluted in PBS (pH 7),
plated onto LBA, and incubated overnight at 37°C.
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pET-24d
pSU312
pRJM-20
pRJM-33
pRJM-21
pRJM-22
pRJM-23
pRJM-24
pRJM-25
pRJM-26
pRJM-27
pRJM-28
pRJM-29
pRJM-30
pRJM-31
pRJM-32
placlux8
pLuxCDAB3

Relevant characteristics

Morgan et al.

RESULTS

Transcription of grvA is growth phase dependent and directly
activated by RcsB. Previous work has shown the response regulator of the rcs phosphorelay system RcsB to be an activator of global
regulator of virulence A (grvA) and both factors to be required for
full bicarbonate induction of the LEE-encoded regulator Ler and
subsequent stimulation of LEE expression in EHEC during exponential-phase growth (20, 21). RcsB is predicted to act upstream of
grvA in the regulation of ler, yet the mechanism underlying the
control of grvA by RcsB is unknown.
The level of transcription of grvA in reporter strain TW14359
grvAB-luxE⁄pluxCDAB3 (EcRJM-89) (Table 1) grown in DMEM
with sodium bicarbonate (44 mM) was the highest during early
exponential-phase growth, rapidly declining as cultures transitioned into postexponential phase (Fig. 1A). When grown in LB,
the level of grvA transcription was similar to that observed when
grown in DMEM; however, the levels were consistently lower over
the first 7 h. Addition of sodium bicarbonate (44 mM) to LB,
previously shown to upregulate RcsB levels (20), had no significant impact on grvA transcription, while overexpression of rcsDB
in trans in TW14359 grvAB-luxE⁄pluxCDAB3 substantially increased the level of grvA transcription when grown on LB agar in
the absence of sodium bicarbonate (Fig. 1A). Thus, the addition of
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bicarbonate alone is not sufficient for upregulation of grvA. That
overexpression of rcsB increased the level of transcription from
the grvA promoter suggests that RcsB may directly activate grvA
transcription. In support of this, two putative tandem RcsB binding sites proximal to a predicted ⫺35 site (nucleotides 1282968 to
1282982 in TW14359) of the grvA promoter (grvAP) have been
described previously (21, 31) (Fig. 1B, Box 1 and Box 2). To test
for interactions between RcsB and the grvA promoter, purified
6⫻His-tagged RcsB was coincubated with a fragment of the core
grvABP element, including putative RcsB binding sites (Fig. 1B,
Frag-2) and analyzed using electrophoretic mobility shift assays.
As anticipated, the 235-bp grvABP fragment was visibly shifted
with the addition of increasing amounts (1 to 12 g) of 6⫻HisRcsB, while no shift was observed for the control fragment (Fig.
1B, Frag-1, and C). These findings suggest that RcsB is a direct
transcriptional activator of grvA and that activation occurs at the
grvA core promoter region containing at least one putative RcsB
binding site.
GrvA is a regulator of pathogenic mechanisms and metabolic
fitness in EHEC. grvA is required for LEE activation by the Rcs
phosphorelay system in EHEC (21). How, in turn, GrvA upregulates LEE expression and the scope of genes under the control of
GrvA are unknown. To explore this, the transcriptomes of EHEC
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FIG 1 Rcs response regulator RcsB directly activates transcription from the grvAB promoter. (A) (Left) Average luciferase activity (in relative light units [RLU])
plotted as a function of time for a single-copy grvAB-luxE fusion grown in DMEM, LB, or LB supplemented with 44 mM NaHCO3. Asterisks denote significance
by Student’s t test (*, P ⬍ 0.05; **, P ⬍ 0.01; n ⱖ 3). Plots at each time point did not vary from the mean by more than 5%. (Right) Growth and grvAB promoter
expression (luciferase activity) (bottom) on LB agar plates for strain TW14359 grvAB-luxE/pluxCDAB3 transformed with empty vector pMPM-K3 (left) or
pMPM::rcsDB (right). (B) (Left) Map of the grvAB promoter and flanking regions in strain TW14359. Fragments for EMSA (Frag-1 and Frag-2) and the
respective primers for probe generation are indicated. Frag-1 is the negative control; Frag-2 contains two putative RcsB binding sites (Box 1 and Box 2). (Right)
Alignment of box 1 from the grvAB promoter with experimentally proven RcsB homodimer boxes for rprA and osmC promoters. Conserved bases are in bold and
underlined. (C) EMSA for RcsB binding to Frag-2 of the grvAB promoter. The wedge denotes the increasing amount of RcsB added (1 to 12 g). For Frag-1
(control), RcsB was added at 0 g (lane ⫺) and 12 g (lane ⫹).
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FIG 2 The GrvA regulon in EHEC strain TW14359. (A) Circular plot of RNA-seq data for EHEC strains TW14359 and TW14359 ⌬grvA. Nucleotide positions
are based on the TW14359 annotation (GenBank accession number NC_013008.1), indicated by the black outer ring. The heat map denotes the fold change in
RPKM for TW14359 ⌬grvA relative to the level of expression in TW14359 for each gene. The two inner histograms indicate the RPKM values of TW14359 (black)
and TW14359 ⌬grvA (red). Plots were generated using Circos (version 0.65; http://www.circos.ca). (B) Number of genes in grvA whose expression is altered
relative to their expression in TW14359 plotted for each ontological group. The levels of expression of a total of 765 genes were altered by ⱖ2-fold; upregulation
and downregulation are indicated.

O157:H7 strain TW14359 and its grvA isogenic derivative
(TW14359 ⌬grvA) were measured by RNA-seq analysis during
exponential-phase growth (OD600 ⫽ 0.5) in LEE-inducing medium (DMEM).
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In TW14359 ⌬grvA, 765 genes were altered in expression ⬎2fold above the RPKM cutoff compared to their expression in
TW14359; of these, 264 were upregulated and 501 were downregulated (Fig. 2; unpublished data). Known virulence-associated
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incubated in a 1:1 ratio with HT-29 intestinal cells, followed by
plating and enumeration on MacConkey differential medium. For
a control strain, lacZ was deleted from wild-type strain TW14359,
and thus, the strain was Lac⫺ and colonies on MacConkey agar
were white, whereas the test strains (TW14359 and genetic derivatives) were Lac⫹, producing pink colonies. For each test strain, an
adherence index was determined from plate counts as the ratio of
the number of CFU per milliliter for the test strain relative to the
number of CFU per milliliter for the Lac⫺ wild-type control
strain.
In agreement with the ler expression data (Fig. 3A), the adherence index of TW14359 ⌬grvA was significantly decreased compared to the adherence indexes of the wild type, TW14359 ⌬gadE,
TW14359 ⌬grvA ⌬gadE, and grvA-complemented strain
TW14359 ⌬grvA/pgrvA (P ⬍ 0.05) but not that of type III secretion-defective strain TW14359 ⌬escN (Fig. 3B). In strains where
gadE was expressed constitutively, the adherence index was uniformly reduced to levels lower than those in all other strains, including TW14359 ⌬escN (P ⬍ 0.001), suggesting that GadE may
impact adherence in both a LEE-dependent and a LEE-independent manner (Fig. 3B). Only in strain TW14359 grlR::kan, in
which the LEE is overexpressed (20), was the adherence index
increased. The results of these experiments are consistent with the
hypothesis that control of the LEE and adherence by GrvA are
directed through the repression of gadE.
Negative regulation of gadE by GrvA requires GadW. GadE is
a negative regulator of LEE expression, acting directly on the LEE1
promoter to repress ler transcription (52, 53). In the preceding
experiments, the upregulation of ler by GrvA was determined to
correspond with gadE repression. Three discrete promoters have
been shown to control transcription of the gadE gene in E. coli
K-12 MG1655 (56). To better understand the molecular basis
underlying the regulation of gadE promoters P1 to P3 by GrvA,
the levels of transcription from four different gadE lacZ reporter constructs in TW14359 and TW14359 ⌬grvA were compared during exponential-phase and stationary-phase growth
in DMEM (Fig. 4A).
During exponential-phase growth, the level of transcription
from gadE-lacZ containing all three gadE promoters (P1 through
P3; Frag-1) was significantly increased in TW14359 ⌬grvA compared to that in TW14359 (P ⬍ 0.01) (Fig. 4A) (55). Promoter
activity from fragments containing the P1 or P3 promoter alone
(Frag-2 and Frag-4, respectively) was also significantly higher in
TW14359 ⌬grvA (P ⬍ 0.05), while activity from the fragment
containing only the P2 promoter (Frag-3) did not differ between
TW14359 ⌬grvA and TW14359. As anticipated, promoter activity
from all fragments increased significantly during stationary-phase
growth for TW14359 (P ⬍ 0.01) yet increased only slightly from
P2 (P ⬍ 0.05). For TW14359 ⌬grvA, promoter activity further
increased only from P1 during stationary phase (P ⬍ 0.01) and
was higher than the activity from P1 in TW14359 (Fig. 4A). This
was predicted to be due to autoactivation of the P1 promoter by
GadE (54), as deletion of gadE in TW14359 ⌬grvA eliminated P1
activation (Frag-2) during exponential-phase growth but had no
effect on P3 activity (Frag-4) (Fig. 4B). On the basis of these findings, it is suspected that the GrvA-dependent regulation of gadE
transcription is directed solely through the P3 promoter.
Transcription from the gadE P3 promoter is directly controlled
by the AFI-encoded regulators GadX and GadW (56), and RNAseq analysis of TW14359 ⌬grvA revealed the levels of expression of
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genes made up 6% of the genes whose expression was altered (8
upregulated, 38 downregulated). The majority of these were LEEencoded structural proteins and secreted effectors, consistent with
the role of GrvA as a positive regulator of LEE expression (Fig. 2A
and B). Twenty-one LEE genes were downregulated in TW14359
⌬grvA, including the LEE-encoded regulator ler, type III secretion
translocon genes espA, espB, espD, and eaeA (encoding intimin),
and the secreted effector tir (translocated intimin receptor) (Table
2). Five non-LEE-encoded effectors (nleC, nleA, nleH2, nleF, and
nleE) were also downregulated in TW14359 ⌬grvA. Genes encoded within the 15-kb genomic acid fitness island (AFI), the
products of which are required for survival at low pH (48), were
upregulated in TW14359 ⌬grvA compared to their level of regulation in TW14359, in which the expression of AFI genes was
barely detectable (Table 2). Most notably, genes of the glutamatedependent acid resistance (GDAR) system were upregulated, including gadA, gadE, gadW, gadX, and the non-AFI-encoded
gadCB operon. Thus, GrvA activates the LEE colonization mechanism while repressing acid resistance systems.
Twenty-six percent of the genes whose expression was altered
(57 upregulated, 140 downregulated) had defined metabolic functions, suggesting a broader role for GrvA in regulation and fitness
(Fig. 2B). This included genes for asparagine synthesis (asnA,
asnB) and arginine degradation (ast operon) (Table 2). Nine percent (23 upregulated, 45 downregulated) were known or predicted regulators, and of these, global nitrogen metabolism regulators ntrC (also glnG) and nac, as well as cbl for sulfonate
utilization, were downregulated. Eight percent (18 upregulated,
42 downregulated) were transport systems, and of these, glutamate (glt operon), glutamine (gln operon, and ammonium
(amtB) transporters were downregulated. Thirty-seven percent
(112 upregulated, 171 downregulated) had unknown or hypothetical functions (Table 2). Genes for zinc binding and transport,
as well as resistance to zinc and other metals, were upregulated in
TW14359 ⌬grvA, including znuA, znuCB, zinT (formerly yodA),
rpmE2, rpmJ, ykgL, and yebA (49–51).
Alterations in the expression of astC (arginine metabolism), ler
(LEE regulator), gadE (acid resistance), and znuC (zinc transport)
were validated by qRT-PCR. Complementation of grvA in trans
(strain TW14359 ⌬grvA/pgrvA) largely restored wild-type expression for ler and znuA but only partially restored expression for
gadE and astC (Table 3). Deletion of rcsB in TW14359 ⌬grvA had
no further significant impact on the expression of ler or any other
targets tested (Table 3).
GrvA requires acid resistance regulator gadE for control of
ler and adherence to intestinal cells. RNA-seq analysis revealed
that deletion of grvA leads to the upregulation of gadE, a known
transcriptional repressor of LEE-encoded regulator ler (52, 53). As
such, the contribution of gadE to GrvA-dependent control of the
LEE and adherence to cultured intestinal epithelial cells was examined.
During exponential-phase growth, gadE transcription is
strongly repressed (54, 55). As such, the level of expression of ler in
TW14359 ⌬gadE only marginally increased compared to that in
TW14359 (Fig. 3A). However, when gadE was constitutively expressed in both TW14359 ⌬grvA and TW14359 ⌬grvA ⌬gadE, ler
expression was reduced to the level of that observed in TW14359
⌬grvA (Fig. 3A) (P ⬍ 0.05).
The effect of the grvA and gadE interaction on in vitro adherence was determined using a competition assay. Strains were co-
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TABLE 2 RNA-seq GrvA transcriptome
RPKMc

Fold change in
⌬grvA mutantb

Wild type

⌬grvA mutant

Gene product description

LEE pathogenicity island genes and genes
for non-LEE-encoded effectors
ECSP_4665
ECSP_4666
ECSP_4667
ECSP_4668
ECSP_4669
ECSP_4670
ECSP_4671
ECSP_4672
ECSP_4673
ECSP_4674
ECSP_4675
ECSP_4676
ECSP_4677
ECSP_4678
ECSP_4679
ECSP_4680
ECSP_4681
ECSP_4682
ECSP_4683
ECSP_4684
ECSP_4685
ECSP_4686
ECSP_4687
ECSP_4688
ECSP_4689
ECSP_4690
ECSP_4691
ECSP_4692
ECSP_4693
ECSP_4694
ECSP_4695
ECSP_4696
ECSP_4697
ECSP_4698
ECSP_4699
ECSP_4700
ECSP_4701
ECSP_4702
ECSP_4703
ECSP_4704
ECSP_4705
ECSP_0061
ECSP_0866
ECSP_0868
ECSP_1702
ECSP_1704
ECSP_1705
ECSP_3954

espF
orf29
escF
cesD2
espB
espD
espA
sepL
escD
eaeA
cesT
tir
map
cesF
espH
escQ
orf16
orf15
escN
escV
orf12
espZ
escI
escJ
sepD
escC
cesD
grlA
grlR
etgA
escU
escT
escS
escR
escL
orf4
cesA
escE
ler
espG
rorf1
espY1
nleC
nleD
nleA
nleH2
nleF
nleE

⫺3.1
⫺3.4
⫺5.8
⫺8.3
⫺6.6
⫺4.5
⫺4.4
⫺4.5
⫺4.0
⫺4.8
⫺5.9
⫺4.0
⫺4.4
ND (⫺)d
⫺4.8
⫺1.9
⫺8.1
⫺1.2
⫺2.7
⫺2.3
⫺1.3
⫺3.5
⫺1.3
⫺2.8
⫺1.3
⫺1.7
⫺1.1
⫺1.1
⫺1.9
⫺1.5
ND (⫺)
ND (⫺)
4.0
⫺1.6
⫺2.9
⫺1.8
⫺1.0
⫺1.1
⫺2.5
⫺3.7
⫺1.0
2.0
⫺2.3
⫺1.7
⫺4.0
2.2
⫺3.7
⫺4.0

16.5
11.9
15.5
46.3
658.8
208.3
165.3
46.8
4.8
75.0
105.0
186.7
27.7
3.4
22.9
9.7
14.7
5.9
16.8
11.6
2.6
78.4
12.7
18.4
2.2
7.8
6.5
15.3
11.4
1.3
1.6
2.0
0.6
4.3
12.2
10.3
2.2
18.3
55.7
4.5
0.6
0.3
4.3
7.3
1.5
3.8
16.2
2.6

5.4
3.5
2.7
5.6
100.5
46.4
37.7
10.3
1.2
15.8
17.7
46.6
6.3
⬍10⫺4
4.8
5.0
1.8
4.9
6.2
5.1
2.0
22.6
9.9
6.6
1.7
4.5
6.0
13.8
5.9
0.9
⬍10⫺4
⬍10⫺4
2.4
2.6
4.2
5.6
2.2
16.2
22.7
1.2
0.6
0.6
1.9
4.4
0.4
8.6
4.4
0.6

LEE-encoded effector
LEE-encoded protein
LEE-encoded protein
Predicted chaperone
Secreted protein EspB
Secreted protein EspD
Secreted protein EspA
LEE-encoded T3S component
LEE-encoded T3S component
Intimin adherence protein
Chaperone
Translocated intimin receptor
LEE-encoded effector
Chaperone
LEE-encoded effector
LEE-encoded protein
LEE-encoded protein
LEE-encoded protein
LEE-encoded ATPase
LEE-encoded protein
LEE-encoded protein
LEE-encoded effector
LEE-encoded protein
LEE-encoded protein
LEE-encoded protein
T3S needle complex subunit
LEE-encoded protein
Global regulator of LEE, activator
Global regulator of LEE, repressor
Lytic transglycosylase
LEE-encoded protein
LEE-encoded protein
LEE-encoded protein
LEE-encoded protein
LEE-encoded protein
LEE-encoded protein
Chaperone
LEE-encoded protein
LEE encoded regulator
LEE encoded effector
LEE-encoded protein
Non-LEE-encoded effector
Non-LEE-encoded effector
Non-LEE-encoded effector
Non-LEE-encoded effector
Non-LEE-encoded effector
Non-LEE-encoded effector
Non-LEE-encoded effector

Metabolism and acid resistance genes
ECSP_0704
ECSP_0705
ECSP_0706
ECSP_0707
ECSP_0906
ECSP_0907
ECSP_0908
ECSP_1977

gltL
gltK
gltJ
gltI
glnQ
glnP
glnH
gadC

⫺3.9
⫺3.0
⫺2.5
⫺3.0
⫺2.3
⫺2.3
⫺1.5
15.6

149.2
31.2
29.9
156.1
277.1
32.1
141.1
1.3

38.4
10.3
12.0
52.4
118.0
13.8
93.5
20.5

Glutamate and aspartate transporter
Glutamate and aspartate transporter
Glutamate and aspartate transporter
Glutamate and aspartate transporter
Glutamine transporter subunit
Glutamine transporter subunit
Glutamine transporter subunit
Glutamate:gamma-aminobutyric acid antiporter
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name

a
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TABLE 2 (Continued)
a

Gene identifier

Metal stress response and
import/export genes
ECSP_0334
ECSP_0335
ECSP_0336
ECSP_0622
ECSP_0623
ECSP_0624
ECSP_0625
ECSP_0626
ECSP_0627
ECSP_0731
ECSP_2430
ECSP_2431
ECSP_2432
ECSP_2433

Fold change in
⌬grvA mutantb

Wild type

⌬grvA mutant

Gene product description

gadB
astE
astB
astD
astA
astC
gdhA
argT
uxaA
uxaC
slp
hdeB
hdeA
hdeD
gadE
mdtE
mdtF
gadW

glnG
glnL
glnA
glnK
amtB
asnC
asnA
asnB
cbl
nac
galR
lysA
lysR

14.6
⫺4.0
⫺5.9
⫺9.1
ND (⫺)
⫺66.0
⫺1.8
⫺3.5
1.7
1.8
2.0
ND (⫹)
ND (⫹)
ND (⫹)
ND (⫹)
ND (⫹)
ND (⫹)
ND (⫹)
1.0
ND (⫹)
ND (⫹)
1.0
ND (⫹)
1.0
ND (⫹)
ND (⫹)
87.3
ND
⫺1.1
⫺3.7
⫺3.7
⫺4.3
ND (⫹)
⫺74.8
⫺2.0
⫺5.0
⫺7.6
⫺4.8
⫺63.5
⫺2.1
⫺4.3
⫺2.8

4.1
9.7
10.9
18.3
25.5
52.4
53.4
89.1
12.6
7.8
37.4
⬍10⫺4
⬍10⫺4
⬍10⫺4
⬍10⫺4
⬍10⫺4
⬍10⫺4
⬍10⫺4
⬍10⫺4
⬍10⫺4
⬍10⫺4
⬍10⫺4
⬍10⫺4
⬍10⫺4
⬍10⫺4
⬍10⫺4
0.2
2.7
78.6
83.9
117.1
745.3
143.4
185.6
5.2
2,647.6
688.2
14.1
32.0
13.2
23.1
2.8

59.5
2.4
1.8
2.0
⬍10⫺4
0.8
23.0
25.3
21.4
13.6
74.3
13.6
134.4
11.7
10.8
11.6
12.9
9.1
0.0
5.0
18.3
⬍10⫺4
3.4
⬍10⫺4
2.6
5.1
16.3
⬍10⫺4
74.4
22.4
31.6
172.4
⬍10⫺4
2.7
2.6
532.5
90.7
2.9
0.5
6.4
5.4
1.0

Glutamate decarboxylase B
Succinylglutamate desuccinylase
Succinylarginine dihydrolase
Succinylglutamic semialdehyde dehydrogenase
Arginine succinyltransferase
Succinylornithine transaminase
Glutamate dehydrogenase
Lysine/arginine/ornithine transporter subunit
Altronate hydrolase
Uronate isomerase
Outer membrane lipoprotein
Acid resistance protein
Acid resistance protein
Acid resistance protein
GDAR activator
Multidrug resistance efflux transporter
Multidrug resistance efflux transporter
DNA-binding transcriptional activator
Hypothetical protein
DNA-binding transcriptional dual regulator
Glutamate decarboxylase A
Cytochrome c peroxidase
Cytoplasmic trehalase
DNA-binding response regulator
DNA-binding transcriptional regulator
Conserved inner membrane protein
Predicted transporter
Hypothetical protein
Hypothetical protein
DNA-binding response regulator
Sensory histidine kinase
Glutamine synthetase
Nitrogen assimilation regulatory protein
Ammonium transporter
DNA-binding transcriptional regulator
Asparagine synthetase A
Asparagine synthetase B
DNA-binding transcriptional activator
DNA-binding transcriptional dual regulator
DNA-binding transcriptional repressor
Diaminopimelate decarboxylase
DNA-binding transcriptional dual regulator

ykgL
rpmJ
rpmE2
cusS
cusR
cusC
cusF
cusB
cusA
fur
yebA
znuA
znuC
znuB

ND (⫹)
170.7
565.7
⫺1.3
1.1
⫺1.0
⫺1.8
⫺1.3
⫺1.4
1.7
4.5
17.7
2.5
4.2

⬍10⫺4
1.7
0.6
7.6
36.3
15.6
47.5
111.6
67.5
38.2
17.0
13.8
4.5
4.6

1.4
284.6
346.5
5.8
38.9
15.0
26.5
82.8
48.0
64.5
75.9
244.0
18.9
11.4

Predicted protein
50S ribosomal protein L36
Zn(II)-responsive ribosomal protein
Sensory histidine kinase
DNA-binding response regulator
Copper/silver efflux system
Periplasmic copper-binding protein
Copper/silver efflux system
Copper/silver efflux system
DNA-binding regulator
Predicted peptidase
High-affinity zinc uptake system
High-affinity zinc uptake system
High-affinity zinc uptake system

gadX
gadA
yhjA
treF
yhjB
yhjC
yhjD
yhjE
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ECSP_1978
ECSP_2312
ECSP_2313
ECSP_2314
ECSP_2315
ECSP_2316
ECSP_2329
ECSP_3185
ECSP_4065
ECSP_4066
ECSP_4486
ECSP_4498
ECSP_4499
ECSP_4500
ECSP_4501
ECSP_4502
ECSP_4503
ECSP_4504
ECSP_4505
ECSP_4506
ECSP_4507
ECSP_4508
ECSP_4509
ECSP_4510
ECSP_4511
ECSP_4512
ECSP_4513
ECSP_4921
ECSP_4922
ECSP_4923
ECSP_4924
ECSP_4925
ECSP_0518
ECSP_0519
ECSP_4793
ECSP_4794
ECSP_0721
ECSP_2651
ECSP_2652
ECSP_3790
ECSP_3791
ECSP_3792

RPKMc

Gene
name

GrvA-Dependent Regulation of EHEC Pathogenesis

TABLE 2 (Continued)
a

Gene identifier
ECSP_2579
ECSP_4263
ECSP_4425

Fold change in
⌬grvA mutantb

Wild type

⌬grvA mutant

Gene product description

zinT
zntR
zntA

163.7
⫺1.1
⫺1.4

2.0
11.4
19.9

328.1
9.9
14.3

Conserved metal-binding protein
DNA-binding transcriptional activator
Zinc, cobalt, and lead efflux system

ddpF
ddpD
ddpC
ddpB
ddpA
ddpX
yedV
yedW
yjiA
yjiX
yjiY

1.1
1.5
1.6
⫺6.5
⫺28.7
ND (⫺)
⫺1.8
1.0
2.8
27.8
3.8
⫺2.4
⫺1.9

2.3
1.0
1.3
3.1
9.3
7.3
2.7
48.2
12.3
0.7
64.6
1,462.1
1,576.0

2.5
1.4
2.1
0.5
0.3
⬍10⫺4
1.4
26.5
34.1
19.5
246.2
620.0
841.5

D-Ala–D-Ala

transporter subunit
transporter subunit
D-Ala–D-Ala transporter subunit
D-Ala–D-Ala transporter subunit
D-Ala–D-Ala transporter subunit
D-Ala–D-Ala dipeptidase
Sensory kinase
DNA-binding regulator
Predicted GTPase
Conserved protein
Predicted protein
Hypothetical protein
Hypothetical protein
D-Ala–D-Ala

a

Based on EHEC O157:H7 strain TW14359 (GenBank accession number NC_013008.1).
Fold change was calculated as the wild-type RPKM value divided by the mutant strain RPKM value.
c
RPKM, reads per kilobase per million mapped reads.
d
ND, not determined; (⫹), upregulated; (⫺), downregulated.
b

both genes to be elevated compared to their levels of expression in
TW14359 (Table 2). It was thus predicted that repression of P3 by
GrvA was mediated through one or both of these regulators. To
test this, the effect of gadX and gadW deletion in TW14359 ⌬grvA
on P3 activity during exponential-phase growth (OD600 ⫽ 0.5) in
DMEM was measured. Only the deletion of gadW was observed to
reduce the level of transcription from P3 (Fig. 4C). Activity from
P3 in TW14359 ⌬gadW and TW14359 ⌬grvA ⌬gadW was reduced
significantly compared to that in TW14359 ⌬grvA (P ⫽ 0.01 and
0.03, respectively) but not compared to that in TW14359. Conversely, activity from P3 was slightly but significantly increased in
TW14359 ⌬grvA ⌬gadX compared to that in TW14359 ⌬grvA
(P ⫽ 0.01) (Fig. 4C). Taken together, these data indicate that GrvA
indirectly represses transcription from the gadE P3 promoter during exponential-phase growth in a manner that is dependent on
gadW.
GrvA is a novel repressor of glutamate-dependent acid resistance. The transcription of GDAR genes is growth phase dependent; expression is tightly controlled and low during exponentialphase growth but increases markedly as cells transition into
stationary phase (57). Correspondingly, exponential-phase cultures are generally acid susceptible, while stationary-phase cultures are acid resistant. Since deletion of grvA was shown to up-

regulate GDAR genes (gadA, gadBC, gadE, gadW, gadX) during
exponential-phase growth, the contribution of GrvA to GDAR
was determined for exponential-phase cultures and was compared
to that of the GDAR phenotype of stationary-phase cultures. In
addition, since RcsB activates grvA transcription and is a dual
regulator of GDAR system genes in E. coli K-12 (28, 58, 59), the
interactions of rcsB and grvA in expression of the GDAR phenotype in EHEC O157:H7 were examined.
As expected, no colonies of wild-type TW14359 grown to
exponential phase could be recovered on LBA following a 1-h
challenge in acidified (pH 2) EG medium (Fig. 5, top). However, for strain TW14359 ⌬grvA, in which GDAR genes are
upregulated during exponential-phase growth, 400 CFU/ml,
corresponding to 9% of the original inoculum, was recovered.
Complementation of TW14359 ⌬grvA with grvA restored acid
sensitivity to wild-type levels. GDAR was abrogated following
deletion of rcsB in TW14359 ⌬grvA, and complementation
with rcsB restored GDAR in TW14359 ⌬grvA ⌬rcsB but not in
TW14359 ⌬rcsB.
In stationary phase, during which GDAR is actively expressed
(57), deletion and complementation of grvA had no effect on survival in acid, with 100% of the initial inoculum being recovered
following a 1-h challenge in acidified EG medium (Fig. 5, bottom).

TABLE 3 qRT-PCR validation of RNA-seq data
Expression unitsa
Strain

ler

gadE

astC

znuA

TW14359
⌬grvA mutant
⌬rcsB ⌬grvA mutant
⌬grvA pgrvA mutant

1,054.77 (51.81)
78.28 (21.68)
127.97 (33.65)
556.98 (180.36)

0.18 (0.06)
61.11 (8.22)
87.87 (4.10)
12.94 (0.81)

111.56 (1.55)
1.21 (0.67)
2.5 (1.49)
6.87 (2.24)

8.02 (2.34)
551.15 (150.90)
622.03 (46.05)
20.46 (8.28)

a
For each gene, expression units relative to the level of rrsH expression were calculated, and standard deviations are in parentheses. Gene name identifiers are based on EHEC strain
TW14359 (GenBank accession number NC_013008.1).
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Genes for other functions
ECSP_1968
ECSP_1969
ECSP_1970
ECSP_1971
ECSP_1972
ECSP_1973
ECSP_2574
ECSP_2575
ECSP_5434
ECSP_5435
ECSP_5436
ECSP_2492
ECSP_4094

RPKMc

Gene
name

Morgan et al.

transcript levels determined by qRT-PCR plotted for TW14359, TW14359
⌬grvA, TW14359 ⌬gadE, TW14359 ⌬grvA ⌬gadE, and complemented
strains TW14359 ⌬gadE/pgadE and TW14359 ⌬grvA ⌬gadE/pgadE grown in
DMEM (OD600 ⫽ 0.5). Plots which differ by lowercase letter differ significantly by Tukey’s HSD test following a significant F test (n ⱖ 3, P ⬍ 0.05).
Error bars denote standard deviations. (B) Adherence ratio box plot for test
strains (TW14359 and genetic derivatives) relative to control strain TW14359
⌬lacZ when cultured with HT-29 colonic epithelial cells (see the text for details). Box plot boundaries represent the 25th and 75th percentiles, whiskers
represent the maximum and minimum values, and the mean adherence ratio is
given by the horizontal line. Asterisks denote a significant difference compared
with the results for TW14359, as determined by t test (n ⱖ 3; *, P ⬍ 0.05; **,
P ⬍ 0.01; ***, P ⬍ 0.001).

Thus, control of GDAR by GrvA is relegated to exponential-phase
growth. In keeping with the requirement for rcsB in stationaryphase GDAR, no growth was observed for TW14359 ⌬rcsB and
TW14359 ⌬grvA ⌬rcsB unless they were complemented with rcsB
(Fig. 5, bottom).
DISCUSSION

This study has examined aspects of grvA transcriptional regulation, has defined the GrvA regulon, and has identified genetic
determinants underlying GrvA-dependent control of discrete
pathogenic mechanisms in EHEC. RcsB, the response regulator of
Rcs phosphorelay in E. coli, is predicted to directly activate transcription of grvA, leading to the upregulation of LEE-dependent
adherence and repression of glutamate-dependent acid resistance
(Fig. 6). While it is not yet clear what cis-acting element(s) is required for RcsB-dependent activation of grvA, this study demonstrated the binding of RcsB to a grvA promoter fragment containing two putative tandem RcsB binding sites located proximal to a
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FIG 3 GrvA requires gadE for control of LEE-dependent adherence. (A) ler

predicted 70 ⫺35 site. These sites share some homology with the
RcsAB box consensus sequence described for rcsA, wza, and flhDC
promoters (30, 60), yet RcsA, which is highly unstable at elevated
temperatures (27), is not required for RcsB-dependent regulation
of the LEE (21), and RcsAB generally bind distal to and upstream
of the promoter core (31, 61, 62). The binding of RcsB to grvA
promoter fragments is more consistent with regulation as a homodimer. RcsB homodimers bind a consensus sequence similar to
the RcsAB box and proximal to the ⫺35 site. Of the two putative
RcsB binding sites in the grvA promoter, the upstream site (Fig.
1B, Box 1) shares similarities with homodimer sites described for
osmC and rprA promoters (63). RcsB has also been shown to negatively regulate grvA expression. In strains of E. coli O157:H7 harboring a 49-bp deletion in rcsB, trans-complementation with
wild-type rcsB decreased grvA expression (64). This was observed,
however, only during culture at 28°C and correlates with reduced
grvA expression during growth at 14°C and 25°C (65). Together,
this suggests that regulation of grvA by RcsB is temperature sensitive. There is precedent for this, as repression of flhDC transcription by RcsB occurs at both low and high temperatures. At low
temperatures, RcsB partners with RcsA (30), whereas at high temperatures, the LEE-encoded regulator GrlA is required (20).
Overexpression of grvA increases transcription from the LEE1
promoter and correspondingly leads to increased adherence (21).
Consistent with this, RNA-seq analysis of TW14359 ⌬grvA in this
study revealed the reduced expression of genes belonging to both
the LEE1 and the LEE2-LEE3 operons, including LEE-encoded
regulator ler, T3S structural genes (esp genes), and the translocated intimin receptor (tir) gene. This study is the first to show
that grvA deletion downregulates non-LEE-encoded T3S effector
genes (nle genes). These proteins broadly impact host signaling
cascades through inhibition of NF-B (NleC, NleE, NleD, and
NleH2) (66–68) and caspase activation (NleF) (69), as well as
interfere with host vesicle trafficking (NleA) (70). How these nle
genes are regulated by GrvA is unknown. One hypothesis is
through its regulatory effects on LEE expression. Both LEE-encoded activators Ler and GrlA regulate nleA expression (71–73).
Moreover, LEE-encoded GrlR has been shown to repress nleB and
nleH (71). However, non-LEE-encoded regulators involved in
quorum sensing (QseA) and nucleoid structuring (H-NS) have
also been implicated in the control of nle gene expression (71, 74).
Whatever the mechanism, these findings suggest a more comprehensive role for GrvA in EHEC pathogenesis that includes the
coordination of T3S-dependent colonization with immune subversion.
This study identifies GrvA to be a new regulator of glutamatedependent acid resistance (GDAR) genes (gad genes) (Fig. 6). Deletion of grvA led to the upregulation of gad regulatory (gadE,
gadW and gadX) and enzymatic/structural (gadA and gadBC)
genes and corresponded with a 100-fold increase in acid survival
by the GDAR mechanism. These findings greatly expand the role
for GrvA in the pathogenic behavior of EHEC to include the control genes essential for the transmission of this pathogen in acidic
food matrices, gastric passage, and a low oral infectious dose.
Since grvA is needed for full bicarbonate induction of the LEE
(20), it is plausible that it helps to coordinate expression of the LEE
and GDAR systems upon entry into the intestine (Fig. 6).
Genes with no direct role in virulence were also shown to be
regulated by GrvA. Most notably, glnG (also ntrC) and nac expression was positively regulated by GrvA. Nitrogen regulatory pro-
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and genetic derivatives. (A) (Top) Activity (in Miller units) for gadE-lacZ promoter fragments Frag-1 through Frag-4 and the vector control (pRS551) plotted for
TW14359 and TW14359 ⌬grvA during exponential-phase (OD600 ⫽ 0.5) and stationary-phase (OD600 ⫽ 2) growth in DMEM. (Bottom) Cartoon of the gadE
promoter and flanking regions. Promoter (P1 to P3) positions and the positions of each cloned promoter fragment (Frag-1 through Frag-4) relative to position
⫹1 of the initiation codon for the gadE ORF are indicated. (B) Activity (in Miller units) plotted for gadE-lacZ promoter fragments Frag-2 (left) and Frag-4 (right)
in TW14359 and mutant derivatives. For panels A and B, asterisks denote significant differences by t test (n ⱖ 3; *, P ⬍ 0.05; **, P ⬍ 0.01). Bars denote standard
deviations. (C) Activity (in Miller units) plotted for the gadE-lacZ P3 promoter in TW14359 and mutant derivatives. Plots which differ by lowercase letter differ
significantly by Tukey’s HSD test following a significant F test (n ⱖ 3, P ⬍ 0.05).

FIG 5 GrvA is a growth phase-dependent repressor of acid resistance. Representative colony-forming units on LB agar for TW14359 and derivative strains
following a 1-h challenge in EG medium (pH 7 versus pH 2) are shown. Cultures were tested for acid resistance during exponential-phase (top) and stationary-phase (bottom) growth in DMEM. See the text for details.
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tein C (NtrC) is a transcriptional activator of nitrogen assimilation control (Nac), and together these regulators are responsible
for coordinating the expression of genes for nitrogen metabolism
under limiting conditions (75). That ntrC and nac are positively
controlled by GrvA is consistent with the reduced expression of
operons for the utilization of glutamate (glt), glutamine (gln), arginine (ast), and asparagine (asn), as well as for the transport of
ammonium (amtB) observed in the TW14359 ⌬grvA background.
How nitrogen availability influences GrvA-dependent control of
these mechanisms and the importance of grvA to nitrogen assimilation are unknown.
GrvA was shown to activate LEE-encoded master regulator ler
through downregulation of gadE, the product of which directly
represses ler transcription in EHEC (52, 53, 76). Negative control
of gadE by GrvA is predicted to occur indirectly through the P3
promoter, requiring an intact gadW (Fig. 6). This is supported by
both gadE-lacZ promoter fusions and RNA-seq analysis in this
study. GadW is an AraC-family regulator that acts as a homodimer or, when partnered with GadX, to control the acid fitness genes gadBC, hdeA, hdeB, and gadE (54, 55, 77, 78). The
details of how GrvA regulates transcription are not yet known. For
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FIG 4 GrvA represses gadE transcription through GadW, determined from ␤-galactosidase activity (in Miller units) for gadE-lacZ promoter fusions in TW14359

Morgan et al.
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FIG 6 Model predicting GrvA-dependent regulation of acid resistance and
LEE-dependent adherence. During exponential-phase growth, GrvA represses
acid resistance (GDAR) and activates LEE-dependent adherence. This requires
the negative regulation of gadW by GrvA. As GadW is a direct activator of gadE,
the central regulator of GDAR, its repression by GrvA downregulates GDAR
gene expression (gadE, gadA, gadBC) and acid resistance. GadE also directly
represses the LEE-encoded regulator ler, the product of which activates the
LEE (5 operons encoding the T3S, other regulators, and toxic effectors). The
repression of GadW/GadE by GrvA leads to activation of the LEE and LEEdependent adherence. Bicarbonate in the intestine is hypothesized to stimulate
GrvA-dependent control of GDAR and the LEE in a manner requiring the Rcs
phosphorelay system. RcsB activates GDAR as a heterodimer with GadE. The
role for GrvB in this regulatory pathway is unknown. GrvA regulates the expression of ⬎700 genes in EHEC O157:H7 strain TW14359. The model is
inferred from the results of experiments performed in this and previous studies
(20, 21, 52, 53, 55). See the text for further details. GDAR, glutamate-dependent acid resistance; LEE, locus of enterocyte effacement.
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